Inflammatory bowel diseases: ulcerative colitis or Crohn's disease
Conditions
Interventions
None listed
Sponsors
Nestlé
Eligibility
Inclusion criteria
Inclusion criteria: IBD patients - 18 years old - in patients where induction therapy is needed - chosen for one of the treatment options (antibiotic treatment or CDED), in consultation with the attending physician.
Exclusion criteria
Exclusion criteria: Severe activity of IBD urging for rescue treatment to avoid surgery, active fistulas as main indication for current induction therapy of CD, pouchitis, signs of active infectious gastro-enteritis/enterocolitis or other signs of infectious agents in stool sample, abnormal renal function (eGFR 20, any other condition which in the opinion of the treating physician would make the patient unsuitable for treatment according to this protocol/enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The results of this prospective study may result in a safe treatment protocol during future pandemics, in which an alternative of immunosuppressive medication may reappear. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety, adverse events, clinical efficacy, need for prednisolone or anti-TNF rescue therapy, and hospitalization will be assessed. | — |
Contacts
Public ContactAndrea van der Meulen
Leiden University Medical Center
Outcome results
None listed